

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 7.55218801 |
| 2 | desmosome organization (GO:0002934) | 7.55217448 |
| 3 | artery development (GO:0060840) | 7.49434986 |
| 4 | L-fucose catabolic process (GO:0042355) | 6.99290450 |
| 5 | fucose catabolic process (GO:0019317) | 6.99290450 |
| 6 | L-fucose metabolic process (GO:0042354) | 6.99290450 |
| 7 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 6.87985703 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 6.71064851 |
| 9 | COPI coating of Golgi vesicle (GO:0048205) | 6.71064851 |
| 10 | prostate gland epithelium morphogenesis (GO:0060740) | 6.64233673 |
| 11 | mitotic cell cycle arrest (GO:0071850) | 6.55792223 |
| 12 | hair cycle (GO:0042633) | 6.50532947 |
| 13 | molting cycle (GO:0042303) | 6.50532947 |
| 14 | establishment of skin barrier (GO:0061436) | 6.43132597 |
| 15 | response to testosterone (GO:0033574) | 6.21876781 |
| 16 | regulation of water loss via skin (GO:0033561) | 6.16376297 |
| 17 | positive regulation of steroid hormone secretion (GO:2000833) | 6.08843278 |
| 18 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.03476977 |
| 19 | mannose metabolic process (GO:0006013) | 5.85194136 |
| 20 | regulation of receptor binding (GO:1900120) | 5.68226989 |
| 21 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 5.65227193 |
| 22 | peptide cross-linking (GO:0018149) | 5.40797854 |
| 23 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.39796649 |
| 24 | fucose metabolic process (GO:0006004) | 5.37108145 |
| 25 | keratinization (GO:0031424) | 5.36690456 |
| 26 | intestinal epithelial cell development (GO:0060576) | 5.26653300 |
| 27 | N-glycan processing (GO:0006491) | 5.19605556 |
| 28 | positive regulation of nuclease activity (GO:0032075) | 5.14239006 |
| 29 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 5.12368182 |
| 30 | sphingoid metabolic process (GO:0046519) | 5.01952338 |
| 31 | pharyngeal system development (GO:0060037) | 5.01580621 |
| 32 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 4.81253330 |
| 33 | hormone catabolic process (GO:0042447) | 4.79605590 |
| 34 | behavioral response to nicotine (GO:0035095) | 4.72583596 |
| 35 | protein retention in ER lumen (GO:0006621) | 4.72374768 |
| 36 | galactose catabolic process (GO:0019388) | 4.72063693 |
| 37 | regulation of nuclease activity (GO:0032069) | 4.67161268 |
| 38 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 4.61063045 |
| 39 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.57028530 |
| 40 | epithelial cell maturation (GO:0002070) | 4.56884037 |
| 41 | positive regulation of growth hormone secretion (GO:0060124) | 4.55027257 |
| 42 | lung secretory cell differentiation (GO:0061140) | 4.54088152 |
| 43 | glandular epithelial cell differentiation (GO:0002067) | 4.53827053 |
| 44 | cellular response to unfolded protein (GO:0034620) | 4.43978215 |
| 45 | diol metabolic process (GO:0034311) | 4.43422251 |
| 46 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.39912231 |
| 47 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 4.31865589 |
| 48 | ER-nucleus signaling pathway (GO:0006984) | 4.27906831 |
| 49 | valine metabolic process (GO:0006573) | 4.27482692 |
| 50 | COPII vesicle coating (GO:0048208) | 4.21063028 |
| 51 | multicellular organismal water homeostasis (GO:0050891) | 4.14206064 |
| 52 | response to endoplasmic reticulum stress (GO:0034976) | 4.12592887 |
| 53 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.12078357 |
| 54 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 4.10994478 |
| 55 | regulation of steroid hormone secretion (GO:2000831) | 4.10186492 |
| 56 | cellular response to topologically incorrect protein (GO:0035967) | 4.09585341 |
| 57 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.04424464 |
| 58 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 4.01884839 |
| 59 | ER overload response (GO:0006983) | 4.00277021 |
| 60 | GDP-mannose metabolic process (GO:0019673) | 3.96952057 |
| 61 | response to pheromone (GO:0019236) | 3.93313090 |
| 62 | potassium ion homeostasis (GO:0055075) | 3.90857474 |
| 63 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.86114671 |
| 64 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.82185842 |
| 65 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.79593759 |
| 66 | keratinocyte differentiation (GO:0030216) | 3.76676479 |
| 67 | regulation of growth hormone secretion (GO:0060123) | 3.71574103 |
| 68 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.69668004 |
| 69 | sphingosine metabolic process (GO:0006670) | 3.69448036 |
| 70 | glucosamine-containing compound catabolic process (GO:1901072) | 3.68482188 |
| 71 | positive regulation of catenin import into nucleus (GO:0035413) | 3.67943991 |
| 72 | platelet dense granule organization (GO:0060155) | 3.66179247 |
| 73 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.59501098 |
| 74 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.54060755 |
| 75 | fucosylation (GO:0036065) | 3.53043282 |
| 76 | regulation of natural killer cell differentiation (GO:0032823) | 3.52682879 |
| 77 | peptidyl-asparagine modification (GO:0018196) | 3.52528664 |
| 78 | DNA deamination (GO:0045006) | 3.52323533 |
| 79 | response to unfolded protein (GO:0006986) | 3.50857149 |
| 80 | vitamin transmembrane transport (GO:0035461) | 3.49348071 |
| 81 | indolalkylamine metabolic process (GO:0006586) | 3.47762761 |
| 82 | hemidesmosome assembly (GO:0031581) | 3.45677717 |
| 83 | tryptophan catabolic process (GO:0006569) | 3.45489404 |
| 84 | indole-containing compound catabolic process (GO:0042436) | 3.45489404 |
| 85 | indolalkylamine catabolic process (GO:0046218) | 3.45489404 |
| 86 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 3.40247825 |
| 87 | intermediate filament organization (GO:0045109) | 3.38860886 |
| 88 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.38717309 |
| 89 | protein autoprocessing (GO:0016540) | 3.38631663 |
| 90 | keratinocyte proliferation (GO:0043616) | 3.37696142 |
| 91 | water homeostasis (GO:0030104) | 3.36720011 |
| 92 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.35815108 |
| 93 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.33054490 |
| 94 | sequestering of metal ion (GO:0051238) | 3.32741953 |
| 95 | negative regulation of mast cell activation (GO:0033004) | 3.31716325 |
| 96 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.30464256 |
| 97 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.29305447 |
| 98 | response to topologically incorrect protein (GO:0035966) | 3.26775827 |
| 99 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 3.26345750 |
| 100 | protein N-linked glycosylation (GO:0006487) | 3.23243632 |
| 101 | detection of light stimulus involved in visual perception (GO:0050908) | 3.21625550 |
| 102 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.21625550 |
| 103 | peptide catabolic process (GO:0043171) | 3.20044615 |
| 104 | epidermis development (GO:0008544) | 3.19550173 |
| 105 | apoptotic cell clearance (GO:0043277) | 3.18059036 |
| 106 | mammary gland alveolus development (GO:0060749) | 3.18038037 |
| 107 | tryptophan metabolic process (GO:0006568) | 3.17498309 |
| 108 | piRNA metabolic process (GO:0034587) | 3.14759622 |
| 109 | zinc ion transport (GO:0006829) | 3.12395354 |
| 110 | hexose catabolic process (GO:0019320) | 3.09110300 |
| 111 | keratinocyte development (GO:0003334) | 3.06850394 |
| 112 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.06678637 |
| 113 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.06327177 |
| 114 | negative regulation of telomere maintenance (GO:0032205) | 3.06234399 |
| 115 | vesicle coating (GO:0006901) | 3.03546000 |
| 116 | kynurenine metabolic process (GO:0070189) | 3.02237339 |
| 117 | epidermal cell differentiation (GO:0009913) | 3.01692967 |
| 118 | cellular modified amino acid catabolic process (GO:0042219) | 2.98951951 |
| 119 | signal peptide processing (GO:0006465) | 2.98136345 |
| 120 | glycerophospholipid catabolic process (GO:0046475) | 2.97578399 |
| 121 | positive regulation of fatty acid transport (GO:2000193) | 2.94717289 |
| 122 | angiotensin maturation (GO:0002003) | 2.92702399 |
| 123 | nucleotide-sugar metabolic process (GO:0009225) | 2.92535787 |
| 124 | beta-amyloid metabolic process (GO:0050435) | 2.90969473 |
| 125 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.86744726 |
| 126 | protein targeting to ER (GO:0045047) | 2.86482072 |
| 127 | regulation of cilium movement (GO:0003352) | 2.85867400 |
| 128 | cornea development in camera-type eye (GO:0061303) | 2.85729468 |
| 129 | amine catabolic process (GO:0009310) | 2.84926680 |
| 130 | cellular biogenic amine catabolic process (GO:0042402) | 2.84926680 |
| 131 | protein targeting to Golgi (GO:0000042) | 2.83724502 |
| 132 | lipoxygenase pathway (GO:0019372) | 2.82240973 |
| 133 | magnesium ion transport (GO:0015693) | 2.81600047 |
| 134 | DNA methylation involved in gamete generation (GO:0043046) | 2.73861006 |
| 135 | intermediate filament cytoskeleton organization (GO:0045104) | 2.73196791 |
| 136 | intermediate filament-based process (GO:0045103) | 2.72452106 |
| 137 | adaptation of signaling pathway (GO:0023058) | 2.69416851 |
| 138 | positive regulation of prostaglandin secretion (GO:0032308) | 2.67035248 |
| 139 | cellular ketone body metabolic process (GO:0046950) | 2.63666714 |
| 140 | positive regulation of icosanoid secretion (GO:0032305) | 2.63332823 |
| 141 | gamma-aminobutyric acid transport (GO:0015812) | 2.62671973 |
| 142 | fatty acid elongation (GO:0030497) | 2.60516669 |
| 143 | protein K11-linked deubiquitination (GO:0035871) | 2.58383251 |
| 144 | indole-containing compound metabolic process (GO:0042430) | 2.57719667 |
| 145 | parturition (GO:0007567) | 2.57405564 |
| 146 | GPI anchor metabolic process (GO:0006505) | 2.55224080 |
| 147 | phospholipid catabolic process (GO:0009395) | 2.54215584 |
| 148 | sulfation (GO:0051923) | 2.54189295 |
| 149 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.53479413 |
| 150 | kidney morphogenesis (GO:0060993) | 2.53435756 |
| 151 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.52777696 |
| 152 | ketone body metabolic process (GO:1902224) | 2.50812166 |
| 153 | nonmotile primary cilium assembly (GO:0035058) | 2.49035980 |
| 154 | dopamine transport (GO:0015872) | 2.47252242 |
| 155 | neuronal action potential (GO:0019228) | 2.46172535 |
| 156 | positive regulation of heat generation (GO:0031652) | 2.44788670 |
| 157 | phosphatidylserine metabolic process (GO:0006658) | 2.44041682 |
| 158 | regulation of action potential (GO:0098900) | 2.42244832 |
| 159 | axoneme assembly (GO:0035082) | 2.41085732 |
| 160 | primary amino compound metabolic process (GO:1901160) | 2.40805654 |
| 161 | reflex (GO:0060004) | 2.40066745 |
| 162 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.38218678 |
| 163 | positive regulation of defense response to virus by host (GO:0002230) | 2.35912319 |
| 164 | regulation of heat generation (GO:0031650) | 2.34321892 |
| 165 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.34184424 |
| 166 | regulation of mesoderm development (GO:2000380) | 2.33225060 |
| 167 | multicellular organism reproduction (GO:0032504) | 2.30951831 |
| 168 | regulation of glucokinase activity (GO:0033131) | 2.30795502 |
| 169 | regulation of hexokinase activity (GO:1903299) | 2.30795502 |
| 170 | protein polyglutamylation (GO:0018095) | 2.29093824 |
| 171 | rhodopsin mediated signaling pathway (GO:0016056) | 2.29034429 |
| 172 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.28448786 |
| 173 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.28442539 |
| 174 | synaptic transmission, cholinergic (GO:0007271) | 2.27788317 |
| 175 | lateral sprouting from an epithelium (GO:0060601) | 2.26920785 |
| 176 | linoleic acid metabolic process (GO:0043651) | 2.26379382 |
| 177 | phosphatidylglycerol metabolic process (GO:0046471) | 2.24844696 |
| 178 | serotonin metabolic process (GO:0042428) | 2.24480272 |
| 179 | positive regulation of glomerulus development (GO:0090193) | 2.23973861 |
| 180 | branching involved in prostate gland morphogenesis (GO:0060442) | 10.2521687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.50749476 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.14976571 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.16191410 |
| 4 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.94730746 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.93320978 |
| 6 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.70811705 |
| 7 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.70811705 |
| 8 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.70811705 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.64358952 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.59730688 |
| 11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.58681327 |
| 12 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.57991191 |
| 13 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.54168772 |
| 14 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 2.49668079 |
| 15 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 2.48035650 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.46527119 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.42039561 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.39797879 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.39494032 |
| 20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.38671333 |
| 21 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.33331889 |
| 22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.25420347 |
| 23 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.22225750 |
| 24 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.22225750 |
| 25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.21753734 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.21588922 |
| 27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.16824418 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.08429825 |
| 29 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.08258148 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.07868549 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.04958430 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.02936567 |
| 33 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.00127251 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.98450604 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.95864794 |
| 36 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.93840902 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.92094570 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.89609607 |
| 39 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.89189492 |
| 40 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.85935036 |
| 41 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.84956656 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.84163086 |
| 43 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.81448117 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.79014454 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.77572812 |
| 46 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.76738128 |
| 47 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.75272548 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.68992785 |
| 49 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.68207860 |
| 50 | ATF3_27146783_Chip-Seq_COLON_Human | 1.66241591 |
| 51 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.65723567 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.64869141 |
| 53 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.64522839 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.64355366 |
| 55 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.62848821 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.62661044 |
| 57 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.61558021 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.59436666 |
| 59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.59410903 |
| 60 | EWS_26573619_Chip-Seq_HEK293_Human | 1.58630036 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57536241 |
| 62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52405982 |
| 63 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.51863504 |
| 64 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51141890 |
| 65 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.51128435 |
| 66 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.50456308 |
| 67 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50101263 |
| 68 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48554001 |
| 69 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.48554001 |
| 70 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.48151970 |
| 71 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46678023 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.46628818 |
| 73 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.46464791 |
| 74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.45293201 |
| 75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.45293201 |
| 76 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.43989793 |
| 77 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.43989793 |
| 78 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.43774986 |
| 79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.43660590 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43145205 |
| 81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.40208980 |
| 82 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39109209 |
| 83 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.38815924 |
| 84 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.38759607 |
| 85 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38753951 |
| 86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37262515 |
| 87 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36163389 |
| 88 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35198054 |
| 89 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.34686558 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34499039 |
| 91 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.33906743 |
| 92 | NCOR_22424771_ChIP-Seq_293T_Human | 1.33782210 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 1.32768407 |
| 94 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.32315455 |
| 95 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.29543235 |
| 96 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.29147314 |
| 97 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.28830961 |
| 98 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28588865 |
| 99 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28347847 |
| 100 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.27684895 |
| 101 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.26408663 |
| 102 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25512398 |
| 103 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25291026 |
| 104 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25291026 |
| 105 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.23598720 |
| 106 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22622896 |
| 107 | CJUN_26792858_Chip-Seq_BT549_Human | 1.22598473 |
| 108 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.22028058 |
| 109 | AR_20517297_ChIP-Seq_VCAP_Human | 1.21316239 |
| 110 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.21207413 |
| 111 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.20903579 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 1.20102540 |
| 113 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.19987623 |
| 114 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.19521973 |
| 115 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.19407933 |
| 116 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18857977 |
| 117 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.18478713 |
| 118 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18174984 |
| 119 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.17300683 |
| 120 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.17300683 |
| 121 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.17104750 |
| 122 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.16068283 |
| 123 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.15722094 |
| 124 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.15582382 |
| 125 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.15581932 |
| 126 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14629633 |
| 127 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14403501 |
| 128 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14091156 |
| 129 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.12925055 |
| 130 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12783477 |
| 131 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12625574 |
| 132 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12200248 |
| 133 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12012663 |
| 134 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11535769 |
| 135 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.10739557 |
| 136 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.10063817 |
| 137 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09556343 |
| 138 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.09514772 |
| 139 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.08393305 |
| 140 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07694849 |
| 141 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.07595740 |
| 142 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.07103886 |
| 143 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06991939 |
| 144 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06811334 |
| 145 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05191814 |
| 146 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04492122 |
| 147 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.04437999 |
| 148 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.03454714 |
| 149 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03382895 |
| 150 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.03086728 |
| 151 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02659170 |
| 152 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02376483 |
| 153 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02323684 |
| 154 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00384059 |
| 155 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.99243428 |
| 156 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98828856 |
| 157 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94273182 |
| 158 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92854553 |
| 159 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.92771930 |
| 160 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.92300893 |
| 161 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.90562234 |
| 162 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89607379 |
| 163 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.89091072 |
| 164 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86312954 |
| 165 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85866773 |
| 166 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85394805 |
| 167 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84109314 |
| 168 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.84001023 |
| 169 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83148211 |
| 170 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83002960 |
| 171 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82572495 |
| 172 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.82170440 |
| 173 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.81658090 |
| 174 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.80861062 |
| 175 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78130642 |
| 176 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.75780672 |
| 177 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.75489385 |
| 178 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.74687461 |
| 179 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.73742023 |
| 180 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.71771227 |
| 181 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.71549912 |
| 182 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.71412072 |
| 183 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.71032576 |
| 184 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.70186048 |
| 185 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.69518429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 6.36352053 |
| 2 | MP0002796_impaired_skin_barrier | 4.87035680 |
| 3 | MP0002166_altered_tumor_susceptibility | 4.14241693 |
| 4 | MP0005310_abnormal_salivary_gland | 4.03039267 |
| 5 | MP0003300_gastrointestinal_ulcer | 3.83015981 |
| 6 | MP0004043_abnormal_pH_regulation | 3.71001969 |
| 7 | MP0010386_abnormal_urinary_bladder | 3.44601927 |
| 8 | MP0005647_abnormal_sex_gland | 3.20662651 |
| 9 | MP0004885_abnormal_endolymph | 3.10416462 |
| 10 | MP0005275_abnormal_skin_tensile | 3.07531270 |
| 11 | MP0002006_tumorigenesis | 3.01521490 |
| 12 | MP0000613_abnormal_salivary_gland | 2.91741438 |
| 13 | MP0000579_abnormal_nail_morphology | 2.88424630 |
| 14 | MP0005501_abnormal_skin_physiology | 2.79611443 |
| 15 | MP0002098_abnormal_vibrissa_morphology | 2.73786510 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.69595986 |
| 17 | MP0003941_abnormal_skin_development | 2.67644729 |
| 18 | MP0003878_abnormal_ear_physiology | 2.59526361 |
| 19 | MP0005377_hearing/vestibular/ear_phenot | 2.59526361 |
| 20 | MP0003195_calcinosis | 2.59435889 |
| 21 | MP0003011_delayed_dark_adaptation | 2.39888032 |
| 22 | MP0000569_abnormal_digit_pigmentation | 2.28559617 |
| 23 | MP0002009_preneoplasia | 2.23241383 |
| 24 | MP0002095_abnormal_skin_pigmentation | 2.22347231 |
| 25 | MP0003136_yellow_coat_color | 2.21165110 |
| 26 | MP0010678_abnormal_skin_adnexa | 2.20654479 |
| 27 | MP0000647_abnormal_sebaceous_gland | 2.18705744 |
| 28 | MP0002653_abnormal_ependyma_morphology | 2.16968549 |
| 29 | MP0001765_abnormal_ion_homeostasis | 2.13649632 |
| 30 | MP0005174_abnormal_tail_pigmentation | 2.07238690 |
| 31 | MP0004264_abnormal_extraembryonic_tissu | 2.06199383 |
| 32 | MP0000537_abnormal_urethra_morphology | 2.03894106 |
| 33 | MP0001216_abnormal_epidermal_layer | 2.02530126 |
| 34 | MP0002060_abnormal_skin_morphology | 2.01917107 |
| 35 | MP0000377_abnormal_hair_follicle | 2.00311959 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.96953477 |
| 37 | MP0000372_irregular_coat_pigmentation | 1.85060425 |
| 38 | MP0005551_abnormal_eye_electrophysiolog | 1.79648781 |
| 39 | MP0002102_abnormal_ear_morphology | 1.79559545 |
| 40 | MP0005451_abnormal_body_composition | 1.77972908 |
| 41 | MP0004381_abnormal_hair_follicle | 1.76125088 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.74725389 |
| 43 | MP0001756_abnormal_urination | 1.73198942 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.70966537 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.70358985 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.69448675 |
| 47 | MP0010771_integument_phenotype | 1.67869103 |
| 48 | MP0001873_stomach_inflammation | 1.65572294 |
| 49 | MP0002132_abnormal_respiratory_system | 1.62991378 |
| 50 | MP0001485_abnormal_pinna_reflex | 1.61799904 |
| 51 | MP0000427_abnormal_hair_cycle | 1.59637240 |
| 52 | MP0000015_abnormal_ear_pigmentation | 1.59033221 |
| 53 | MP0005379_endocrine/exocrine_gland_phen | 1.58586235 |
| 54 | MP0003646_muscle_fatigue | 1.57782358 |
| 55 | MP0005171_absent_coat_pigmentation | 1.56277742 |
| 56 | MP0001188_hyperpigmentation | 1.54647134 |
| 57 | MP0009046_muscle_twitch | 1.49642918 |
| 58 | MP0002254_reproductive_system_inflammat | 1.48522636 |
| 59 | MP0004142_abnormal_muscle_tone | 1.46429585 |
| 60 | MP0008877_abnormal_DNA_methylation | 1.45811991 |
| 61 | MP0005646_abnormal_pituitary_gland | 1.44930092 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 1.44156558 |
| 63 | MP0000566_synostosis | 1.43473311 |
| 64 | MP0001984_abnormal_olfaction | 1.41226292 |
| 65 | MP0006292_abnormal_olfactory_placode | 1.41138416 |
| 66 | MP0009764_decreased_sensitivity_to | 1.40883283 |
| 67 | MP0001346_abnormal_lacrimal_gland | 1.40607092 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 1.40159386 |
| 69 | MP0000383_abnormal_hair_follicle | 1.37827594 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35843599 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 1.33268007 |
| 72 | MP0000538_abnormal_urinary_bladder | 1.32629006 |
| 73 | MP0004947_skin_inflammation | 1.29132064 |
| 74 | MP0005253_abnormal_eye_physiology | 1.27978778 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 1.27559583 |
| 76 | MP0001968_abnormal_touch/_nociception | 1.27161182 |
| 77 | MP0003866_abnormal_defecation | 1.26519890 |
| 78 | MP0000516_abnormal_urinary_system | 1.26428485 |
| 79 | MP0005367_renal/urinary_system_phenotyp | 1.26428485 |
| 80 | MP0005220_abnormal_exocrine_pancreas | 1.25710408 |
| 81 | MP0002163_abnormal_gland_morphology | 1.25387985 |
| 82 | MP0008872_abnormal_physiological_respon | 1.24541745 |
| 83 | MP0005671_abnormal_response_to | 1.22816977 |
| 84 | MP0009745_abnormal_behavioral_response | 1.22785199 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 1.21473518 |
| 86 | MP0005058_abnormal_lysosome_morphology | 1.18296887 |
| 87 | MP0002736_abnormal_nociception_after | 1.16335830 |
| 88 | MP0002638_abnormal_pupillary_reflex | 1.15726063 |
| 89 | MP0000467_abnormal_esophagus_morphology | 1.14488923 |
| 90 | MP0002295_abnormal_pulmonary_circulatio | 1.14250896 |
| 91 | MP0000762_abnormal_tongue_morphology | 1.13405446 |
| 92 | MP0003315_abnormal_perineum_morphology | 1.13016295 |
| 93 | MP0003566_abnormal_cell_adhesion | 1.12491607 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 1.11619640 |
| 95 | MP0006054_spinal_hemorrhage | 1.10005438 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 1.08725195 |
| 97 | MP0000367_abnormal_coat/_hair | 1.05643288 |
| 98 | MP0002272_abnormal_nervous_system | 1.04334050 |
| 99 | MP0002938_white_spotting | 1.02377019 |
| 100 | MP0009643_abnormal_urine_homeostasis | 1.01862105 |
| 101 | MP0002909_abnormal_adrenal_gland | 1.01565498 |
| 102 | MP0009780_abnormal_chondrocyte_physiolo | 1.01524458 |
| 103 | MP0002148_abnormal_hypersensitivity_rea | 1.01136776 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.98708484 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 0.97571260 |
| 106 | MP0001944_abnormal_pancreas_morphology | 0.97075867 |
| 107 | MP0004147_increased_porphyrin_level | 0.94262581 |
| 108 | MP0008789_abnormal_olfactory_epithelium | 0.94059917 |
| 109 | MP0009931_abnormal_skin_appearance | 0.93619107 |
| 110 | MP0003880_abnormal_central_pattern | 0.89238688 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.88827791 |
| 112 | MP0002064_seizures | 0.87456908 |
| 113 | MP0000627_abnormal_mammary_gland | 0.87421760 |
| 114 | MP0004742_abnormal_vestibular_system | 0.87355710 |
| 115 | MP0001970_abnormal_pain_threshold | 0.86797524 |
| 116 | MP0004133_heterotaxia | 0.85318087 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.85298735 |
| 118 | MP0003724_increased_susceptibility_to | 0.84007050 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.82546806 |
| 120 | MP0005389_reproductive_system_phenotype | 0.81505996 |
| 121 | MP0010155_abnormal_intestine_physiology | 0.80990551 |
| 122 | MP0002733_abnormal_thermal_nociception | 0.79364376 |
| 123 | MP0005645_abnormal_hypothalamus_physiol | 0.79352356 |
| 124 | MP0001191_abnormal_skin_condition | 0.78665734 |
| 125 | MP0003890_abnormal_embryonic-extraembry | 0.78126802 |
| 126 | MP0006276_abnormal_autonomic_nervous | 0.77834469 |
| 127 | MP0001986_abnormal_taste_sensitivity | 0.77806995 |
| 128 | MP0002139_abnormal_hepatobiliary_system | 0.77672116 |
| 129 | MP0001324_abnormal_eye_pigmentation | 0.77445093 |
| 130 | MP0000685_abnormal_immune_system | 0.76589560 |
| 131 | MP0002572_abnormal_emotion/affect_behav | 0.76301515 |
| 132 | MP0002693_abnormal_pancreas_physiology | 0.76162779 |
| 133 | MP0005076_abnormal_cell_differentiation | 0.75755636 |
| 134 | MP0003045_fibrosis | 0.75625105 |
| 135 | MP0000631_abnormal_neuroendocrine_gland | 0.75415324 |
| 136 | MP0003787_abnormal_imprinting | 0.75288824 |
| 137 | MP0001905_abnormal_dopamine_level | 0.74641233 |
| 138 | MP0001486_abnormal_startle_reflex | 0.73975140 |
| 139 | MP0000026_abnormal_inner_ear | 0.73665426 |
| 140 | MP0005084_abnormal_gallbladder_morpholo | 0.72336261 |
| 141 | MP0002111_abnormal_tail_morphology | 0.72102707 |
| 142 | MP0005365_abnormal_bile_salt | 0.70252242 |
| 143 | MP0001919_abnormal_reproductive_system | 0.69471366 |
| 144 | MP0005167_abnormal_blood-brain_barrier | 0.69427357 |
| 145 | MP0005023_abnormal_wound_healing | 0.67920893 |
| 146 | MP0003638_abnormal_response/metabolism_ | 0.66819610 |
| 147 | MP0002896_abnormal_bone_mineralization | 0.66411591 |
| 148 | MP0003137_abnormal_impulse_conducting | 0.64984451 |
| 149 | MP0002229_neurodegeneration | 0.63350157 |
| 150 | MP0004215_abnormal_myocardial_fiber | 0.62953887 |
| 151 | MP0000470_abnormal_stomach_morphology | 0.61623588 |
| 152 | MP0005332_abnormal_amino_acid | 0.60607988 |
| 153 | MP0002877_abnormal_melanocyte_morpholog | 0.58446447 |
| 154 | MP0000534_abnormal_ureter_morphology | 0.58372158 |
| 155 | MP0000681_abnormal_thyroid_gland | 0.56731252 |
| 156 | MP0009379_abnormal_foot_pigmentation | 0.55801908 |
| 157 | MP0003936_abnormal_reproductive_system | 0.54650698 |
| 158 | MP0001243_abnormal_dermal_layer | 0.53011201 |
| 159 | MP0003959_abnormal_lean_body | 0.52564876 |
| 160 | MP0002277_abnormal_respiratory_mucosa | 0.52555890 |
| 161 | MP0002234_abnormal_pharynx_morphology | 0.52191262 |
| 162 | MP0004145_abnormal_muscle_electrophysio | 0.51390400 |
| 163 | MP0009384_cardiac_valve_regurgitation | 0.50405355 |
| 164 | MP0000477_abnormal_intestine_morphology | 0.49502179 |
| 165 | MP0003186_abnormal_redox_activity | 0.48654123 |
| 166 | MP0005166_decreased_susceptibility_to | 0.48271943 |
| 167 | MP0008438_abnormal_cutaneous_collagen | 0.48200302 |
| 168 | MP0002135_abnormal_kidney_morphology | 0.46941871 |
| 169 | MP0003868_abnormal_feces_composition | 0.46171359 |
| 170 | MP0001784_abnormal_fluid_regulation | 0.45403895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cochlea (HP:0000375) | 7.04351108 |
| 2 | Woolly hair (HP:0002224) | 5.60227146 |
| 3 | Hypotrichosis (HP:0001006) | 5.16792900 |
| 4 | Pili torti (HP:0003777) | 5.00645202 |
| 5 | Right ventricular cardiomyopathy (HP:0011663) | 4.94721781 |
| 6 | Morphological abnormality of the inner ear (HP:0011390) | 4.74562228 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.64842012 |
| 8 | Abnormality of nail color (HP:0100643) | 4.55280327 |
| 9 | Abnormality of secondary sexual hair (HP:0009888) | 4.31592877 |
| 10 | Abnormality of the axillary hair (HP:0100134) | 4.31592877 |
| 11 | Increased IgE level (HP:0003212) | 4.04911661 |
| 12 | Palmoplantar hyperkeratosis (HP:0000972) | 3.97590297 |
| 13 | Onycholysis (HP:0001806) | 3.93814288 |
| 14 | Plantar hyperkeratosis (HP:0007556) | 3.93238691 |
| 15 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.86215292 |
| 16 | Palmar hyperkeratosis (HP:0010765) | 3.69106999 |
| 17 | Pancreatic cysts (HP:0001737) | 3.62962211 |
| 18 | Abnormality of the intrinsic pathway (HP:0010989) | 3.62055290 |
| 19 | Lip pit (HP:0100267) | 3.47555215 |
| 20 | Abnormal hair laboratory examination (HP:0003328) | 3.38603267 |
| 21 | Furrowed tongue (HP:0000221) | 3.38341968 |
| 22 | Congenital stationary night blindness (HP:0007642) | 3.33603843 |
| 23 | True hermaphroditism (HP:0010459) | 3.26794600 |
| 24 | Testicular atrophy (HP:0000029) | 3.26109292 |
| 25 | Dysostosis multiplex (HP:0000943) | 3.26104026 |
| 26 | Pancreatic fibrosis (HP:0100732) | 3.19430650 |
| 27 | Abnormality of midbrain morphology (HP:0002418) | 3.11433586 |
| 28 | Molar tooth sign on MRI (HP:0002419) | 3.11433586 |
| 29 | Oral leukoplakia (HP:0002745) | 3.10795533 |
| 30 | Hypomagnesemia (HP:0002917) | 3.07996866 |
| 31 | Curly hair (HP:0002212) | 3.02721652 |
| 32 | Gangrene (HP:0100758) | 3.01294675 |
| 33 | Nail dystrophy (HP:0008404) | 2.92268569 |
| 34 | Fragile nails (HP:0001808) | 2.90729742 |
| 35 | Nephronophthisis (HP:0000090) | 2.86000875 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.85702119 |
| 37 | Mucopolysacchariduria (HP:0008155) | 2.85702119 |
| 38 | Achilles tendon contracture (HP:0001771) | 2.83833198 |
| 39 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.77217960 |
| 40 | Natal tooth (HP:0000695) | 2.75410090 |
| 41 | Corneal erosion (HP:0200020) | 2.73596977 |
| 42 | Ectropion (HP:0000656) | 2.71076863 |
| 43 | Widely patent fontanelles and sutures (HP:0004492) | 2.70387000 |
| 44 | Potter facies (HP:0002009) | 2.68352330 |
| 45 | Facial shape deformation (HP:0011334) | 2.68352330 |
| 46 | Milia (HP:0001056) | 2.64146314 |
| 47 | Erythema (HP:0010783) | 2.62621458 |
| 48 | Abnormality of magnesium homeostasis (HP:0004921) | 2.62616496 |
| 49 | Hypoplasia of the uterus (HP:0000013) | 2.60794709 |
| 50 | Parakeratosis (HP:0001036) | 2.58201618 |
| 51 | Subcapsular cataract (HP:0000523) | 2.58063935 |
| 52 | Abnormality of the renal cortex (HP:0011035) | 2.54855969 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.54545866 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.54545866 |
| 55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.54545866 |
| 56 | Abnormality of the Achilles tendon (HP:0005109) | 2.53992449 |
| 57 | Conjunctival hamartoma (HP:0100780) | 2.53863166 |
| 58 | Thick nail (HP:0001805) | 2.53550932 |
| 59 | Hyperglycinuria (HP:0003108) | 2.52052351 |
| 60 | Hypohidrosis (HP:0000966) | 2.50781202 |
| 61 | Abnormality of the renal medulla (HP:0100957) | 2.50421598 |
| 62 | Type II lissencephaly (HP:0007260) | 2.47994407 |
| 63 | Myopathic facies (HP:0002058) | 2.43236676 |
| 64 | Hyporeflexia of lower limbs (HP:0002600) | 2.40982007 |
| 65 | Intention tremor (HP:0002080) | 2.39283013 |
| 66 | Medial flaring of the eyebrow (HP:0010747) | 2.38983463 |
| 67 | Brittle hair (HP:0002299) | 2.37920397 |
| 68 | Abnormal drinking behavior (HP:0030082) | 2.33410424 |
| 69 | Polydipsia (HP:0001959) | 2.33410424 |
| 70 | Congenital, generalized hypertrichosis (HP:0004540) | 2.33333759 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 2.31118425 |
| 72 | Hydroxyprolinuria (HP:0003080) | 2.31118425 |
| 73 | Hypoplastic labia majora (HP:0000059) | 2.30413539 |
| 74 | Absent hair (HP:0002298) | 2.29766357 |
| 75 | Sparse eyelashes (HP:0000653) | 2.29251437 |
| 76 | Popliteal pterygium (HP:0009756) | 2.29147457 |
| 77 | Tubular atrophy (HP:0000092) | 2.28802164 |
| 78 | Slow-growing hair (HP:0002217) | 2.28766494 |
| 79 | Abnormality of hair growth rate (HP:0011363) | 2.28766494 |
| 80 | Hyperventilation (HP:0002883) | 2.25529917 |
| 81 | Duplicated collecting system (HP:0000081) | 2.25012611 |
| 82 | Hypoplasia of the pons (HP:0012110) | 2.23204396 |
| 83 | Male infertility (HP:0003251) | 2.22041504 |
| 84 | Advanced eruption of teeth (HP:0006288) | 2.21744264 |
| 85 | Conical tooth (HP:0000698) | 2.20385872 |
| 86 | Erythroderma (HP:0001019) | 2.17506808 |
| 87 | Abnormality of the renal collecting system (HP:0004742) | 2.17362211 |
| 88 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.15880693 |
| 89 | Abolished electroretinogram (ERG) (HP:0000550) | 2.15704132 |
| 90 | Rectal prolapse (HP:0002035) | 2.14199272 |
| 91 | Pendular nystagmus (HP:0012043) | 2.13381021 |
| 92 | Cystic liver disease (HP:0006706) | 2.12859015 |
| 93 | Decreased central vision (HP:0007663) | 2.10352432 |
| 94 | Decreased circulating renin level (HP:0003351) | 2.10318937 |
| 95 | Agitation (HP:0000713) | 2.09777266 |
| 96 | Abnormal blistering of the skin (HP:0008066) | 2.09048388 |
| 97 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.08144542 |
| 98 | Aplasia of the phalanges of the hand (HP:0009802) | 2.08144542 |
| 99 | Aplasia involving bones of the extremities (HP:0009825) | 2.08144542 |
| 100 | Inability to walk (HP:0002540) | 2.07519139 |
| 101 | Stomatitis (HP:0010280) | 2.07457109 |
| 102 | Attenuation of retinal blood vessels (HP:0007843) | 2.06710220 |
| 103 | Sparse lateral eyebrow (HP:0005338) | 2.03549021 |
| 104 | Absent/shortened dynein arms (HP:0200106) | 2.01595274 |
| 105 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.01595274 |
| 106 | Abnormality of the labia majora (HP:0012881) | 2.01452226 |
| 107 | Reduced antithrombin III activity (HP:0001976) | 2.01378717 |
| 108 | Alopecia of scalp (HP:0002293) | 2.00609350 |
| 109 | Large for gestational age (HP:0001520) | 2.00071076 |
| 110 | Exocrine pancreatic insufficiency (HP:0001738) | 1.98976019 |
| 111 | Coxa valga (HP:0002673) | 1.98353792 |
| 112 | Aortic aneurysm (HP:0004942) | 1.97900597 |
| 113 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.95577179 |
| 114 | Abnormality of the pons (HP:0007361) | 1.93310573 |
| 115 | Barrel-shaped chest (HP:0001552) | 1.93171271 |
| 116 | Stomach cancer (HP:0012126) | 1.92228936 |
| 117 | Keratoconus (HP:0000563) | 1.92085159 |
| 118 | Increased corneal curvature (HP:0100692) | 1.92085159 |
| 119 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.90176871 |
| 120 | Gait imbalance (HP:0002141) | 1.89210459 |
| 121 | Ulnar deviation of the wrist (HP:0003049) | 1.89002537 |
| 122 | Hypothermia (HP:0002045) | 1.88699995 |
| 123 | Amelogenesis imperfecta (HP:0000705) | 1.88691541 |
| 124 | Fair hair (HP:0002286) | 1.88645441 |
| 125 | Laryngomalacia (HP:0001601) | 1.88299291 |
| 126 | Abnormality of glycine metabolism (HP:0010895) | 1.87758656 |
| 127 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.87758656 |
| 128 | Chronic hepatic failure (HP:0100626) | 1.87097604 |
| 129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86259647 |
| 130 | Progressive inability to walk (HP:0002505) | 1.86182163 |
| 131 | Absent eyelashes (HP:0000561) | 1.85334613 |
| 132 | Beaking of vertebral bodies (HP:0004568) | 1.84316237 |
| 133 | Biliary tract neoplasm (HP:0100574) | 1.83579775 |
| 134 | Polar cataract (HP:0010696) | 1.83577646 |
| 135 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.83304630 |
| 136 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.83304630 |
| 137 | Abnormal protein glycosylation (HP:0012346) | 1.83304630 |
| 138 | Abnormal glycosylation (HP:0012345) | 1.83304630 |
| 139 | Congenital primary aphakia (HP:0007707) | 1.81383415 |
| 140 | Neck muscle weakness (HP:0000467) | 1.81103842 |
| 141 | Congenital hepatic fibrosis (HP:0002612) | 1.80910802 |
| 142 | Polyuria (HP:0000103) | 1.80586124 |
| 143 | Pruritus (HP:0000989) | 1.79988422 |
| 144 | Palmoplantar keratoderma (HP:0000982) | 1.78598023 |
| 145 | Hamartoma of the eye (HP:0010568) | 1.78454426 |
| 146 | Lissencephaly (HP:0001339) | 1.78351116 |
| 147 | Acanthosis nigricans (HP:0000956) | 1.77436548 |
| 148 | Abnormal foot bone ossification (HP:0010675) | 1.76474353 |
| 149 | Gaze-evoked nystagmus (HP:0000640) | 1.76116440 |
| 150 | Upper limb muscle weakness (HP:0003484) | 1.74410501 |
| 151 | Concave nail (HP:0001598) | 1.73549798 |
| 152 | Methylmalonic acidemia (HP:0002912) | 1.73017030 |
| 153 | Follicular hyperkeratosis (HP:0007502) | 1.72237182 |
| 154 | Pustule (HP:0200039) | 1.72111336 |
| 155 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.72075920 |
| 156 | Hemiparesis (HP:0001269) | 1.71962795 |
| 157 | Widely spaced teeth (HP:0000687) | 1.71623379 |
| 158 | Nephrogenic diabetes insipidus (HP:0009806) | 1.70672532 |
| 159 | Abnormality of alanine metabolism (HP:0010916) | 1.69574121 |
| 160 | Hyperalaninemia (HP:0003348) | 1.69574121 |
| 161 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.69574121 |
| 162 | Anencephaly (HP:0002323) | 1.67794963 |
| 163 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.67145268 |
| 164 | Renal cortical cysts (HP:0000803) | 1.66803542 |
| 165 | Febrile seizures (HP:0002373) | 1.66092277 |
| 166 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.65630459 |
| 167 | Sclerocornea (HP:0000647) | 1.64720995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 6.42339480 |
| 2 | MST4 | 5.36806709 |
| 3 | FRK | 5.17369611 |
| 4 | TAOK3 | 4.67979251 |
| 5 | ERN1 | 4.59075758 |
| 6 | ADRBK2 | 3.70176552 |
| 7 | LATS1 | 3.63874001 |
| 8 | BMPR1B | 3.05655948 |
| 9 | ACVR1B | 2.90535205 |
| 10 | MAPKAPK3 | 2.75773428 |
| 11 | EEF2K | 2.62628733 |
| 12 | MAP3K2 | 2.62051496 |
| 13 | TGFBR1 | 2.52784551 |
| 14 | ZAK | 2.47338865 |
| 15 | BCKDK | 2.45553131 |
| 16 | TXK | 2.42987109 |
| 17 | EPHA2 | 2.26949375 |
| 18 | WNK3 | 2.15967435 |
| 19 | FER | 2.15526932 |
| 20 | PINK1 | 2.15243024 |
| 21 | MAP4K2 | 2.13398235 |
| 22 | SCYL2 | 2.10099085 |
| 23 | SIK1 | 1.97927792 |
| 24 | TLK1 | 1.97554243 |
| 25 | WNK4 | 1.96411802 |
| 26 | GRK7 | 1.81791686 |
| 27 | RPS6KB2 | 1.80887950 |
| 28 | MAP3K4 | 1.75430837 |
| 29 | TNIK | 1.62696633 |
| 30 | MST1R | 1.53713297 |
| 31 | MAPK13 | 1.51504020 |
| 32 | MAP3K3 | 1.39914567 |
| 33 | PDK2 | 1.39825511 |
| 34 | TNK2 | 1.34711021 |
| 35 | PIK3CG | 1.34589121 |
| 36 | IKBKB | 1.32085693 |
| 37 | DAPK2 | 1.30764050 |
| 38 | CASK | 1.29975494 |
| 39 | INSRR | 1.23080937 |
| 40 | OXSR1 | 1.20029030 |
| 41 | NUAK1 | 1.16875188 |
| 42 | JAK3 | 1.15391016 |
| 43 | IRAK1 | 1.14952336 |
| 44 | MYLK | 1.12667259 |
| 45 | PTK6 | 1.11228060 |
| 46 | LRRK2 | 1.11157946 |
| 47 | EIF2AK3 | 1.09392601 |
| 48 | DYRK2 | 1.03750229 |
| 49 | PAK3 | 1.01858360 |
| 50 | TRIM28 | 0.96833851 |
| 51 | PRKCG | 0.96486203 |
| 52 | MKNK2 | 0.96378945 |
| 53 | MET | 0.96131931 |
| 54 | TRIB3 | 0.95100504 |
| 55 | PNCK | 0.94508754 |
| 56 | MAP2K6 | 0.93303402 |
| 57 | TESK1 | 0.93246489 |
| 58 | TTN | 0.91310656 |
| 59 | PDGFRA | 0.87938371 |
| 60 | CAMKK2 | 0.86969673 |
| 61 | LMTK2 | 0.85914208 |
| 62 | TRPM7 | 0.85428972 |
| 63 | STK24 | 0.84725804 |
| 64 | STK10 | 0.83126057 |
| 65 | PRKCI | 0.81972453 |
| 66 | MAP2K7 | 0.79469620 |
| 67 | TAF1 | 0.76085193 |
| 68 | PLK2 | 0.74346203 |
| 69 | TIE1 | 0.73537642 |
| 70 | GRK1 | 0.73269123 |
| 71 | MARK1 | 0.73006742 |
| 72 | NEK6 | 0.72640013 |
| 73 | PKN1 | 0.72208467 |
| 74 | PIK3CA | 0.71618778 |
| 75 | NME1 | 0.70282360 |
| 76 | GRK5 | 0.70158605 |
| 77 | CSNK1G2 | 0.69644063 |
| 78 | KIT | 0.69408798 |
| 79 | JAK2 | 0.69033120 |
| 80 | CHUK | 0.68912310 |
| 81 | RPS6KA2 | 0.67930312 |
| 82 | JAK1 | 0.66379296 |
| 83 | MAPK15 | 0.64969184 |
| 84 | STK3 | 0.64793111 |
| 85 | HIPK2 | 0.64030455 |
| 86 | IKBKE | 0.63352141 |
| 87 | ERBB3 | 0.62868371 |
| 88 | MAP2K2 | 0.62389132 |
| 89 | TGFBR2 | 0.62388471 |
| 90 | NLK | 0.61537329 |
| 91 | STK39 | 0.59934765 |
| 92 | IRAK3 | 0.59876963 |
| 93 | CSNK1G3 | 0.59058129 |
| 94 | NTRK3 | 0.58607460 |
| 95 | CSNK1A1L | 0.58459936 |
| 96 | EPHB1 | 0.57326459 |
| 97 | CSNK1G1 | 0.56393471 |
| 98 | MUSK | 0.55630113 |
| 99 | VRK1 | 0.52786952 |
| 100 | PTK2B | 0.52537073 |
| 101 | PHKG1 | 0.51983247 |
| 102 | PHKG2 | 0.51983247 |
| 103 | TEC | 0.51678779 |
| 104 | EPHA3 | 0.51535843 |
| 105 | NME2 | 0.51200648 |
| 106 | NTRK2 | 0.48573820 |
| 107 | FLT3 | 0.48102791 |
| 108 | NTRK1 | 0.45685722 |
| 109 | PKN2 | 0.45012428 |
| 110 | ABL2 | 0.44535295 |
| 111 | STK11 | 0.44025246 |
| 112 | STK38L | 0.43969946 |
| 113 | BRSK2 | 0.43819741 |
| 114 | MATK | 0.41427610 |
| 115 | PRKACA | 0.40961161 |
| 116 | STK38 | 0.40741672 |
| 117 | MAP2K4 | 0.40262655 |
| 118 | SGK494 | 0.40138616 |
| 119 | SGK223 | 0.40138616 |
| 120 | BCR | 0.39650081 |
| 121 | EPHB2 | 0.39580441 |
| 122 | CAMK2A | 0.39271414 |
| 123 | BTK | 0.39000913 |
| 124 | CSF1R | 0.38353932 |
| 125 | ABL1 | 0.38322789 |
| 126 | DYRK3 | 0.38091504 |
| 127 | ITK | 0.37962657 |
| 128 | SYK | 0.36642681 |
| 129 | LATS2 | 0.36613467 |
| 130 | IRAK4 | 0.35633594 |
| 131 | MAP3K1 | 0.34078218 |
| 132 | DMPK | 0.34058741 |
| 133 | PRKAA2 | 0.34049080 |
| 134 | MAP2K3 | 0.33082893 |
| 135 | MAP3K6 | 0.32556604 |
| 136 | SGK2 | 0.32535259 |
| 137 | PRKCE | 0.31518584 |
| 138 | FGFR3 | 0.31452393 |
| 139 | RPS6KB1 | 0.31067011 |
| 140 | PDPK1 | 0.31049655 |
| 141 | PRKD1 | 0.29649152 |
| 142 | IGF1R | 0.29549809 |
| 143 | PDK1 | 0.29514341 |
| 144 | ADRBK1 | 0.29340753 |
| 145 | PAK2 | 0.29310930 |
| 146 | FGFR1 | 0.28761888 |
| 147 | PRKCA | 0.28665365 |
| 148 | ROCK1 | 0.28222599 |
| 149 | TAOK1 | 0.28036296 |
| 150 | CDC42BPA | 0.27879169 |
| 151 | CSNK1D | 0.27708642 |
| 152 | RPS6KA5 | 0.27210928 |
| 153 | TESK2 | 0.27164774 |
| 154 | RPS6KA1 | 0.26001975 |
| 155 | ROCK2 | 0.25022048 |
| 156 | MAPKAPK5 | 0.24942446 |
| 157 | RPS6KC1 | 0.24837801 |
| 158 | RPS6KL1 | 0.24837801 |
| 159 | MTOR | 0.22802847 |
| 160 | FGFR2 | 0.22028912 |
| 161 | PRKCQ | 0.21868740 |
| 162 | RET | 0.19575578 |
| 163 | PTK2 | 0.19561947 |
| 164 | MAP3K8 | 0.19439105 |
| 165 | PRKD2 | 0.19131294 |
| 166 | MAPKAPK2 | 0.19102242 |
| 167 | LIMK1 | 0.15545818 |
| 168 | FYN | 0.15070599 |
| 169 | TYK2 | 0.12845331 |
| 170 | RPS6KA6 | 0.12354226 |
| 171 | MAP3K7 | 0.11772037 |
| 172 | CSNK2A2 | 0.11614066 |
| 173 | CSNK1A1 | 0.09620833 |
| 174 | PDGFRB | 0.09097045 |
| 175 | PRKAA1 | 0.09045638 |
| 176 | DDR2 | 0.08726259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 6.65699644 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.78232167 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 4.66658121 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 3.49436120 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.43504088 |
| 6 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.68029882 |
| 7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.54649691 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.51348183 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.20305371 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.12726774 |
| 11 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.97056672 |
| 12 | Prostate cancer_Homo sapiens_hsa05215 | 1.96883043 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.94299703 |
| 14 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.92310461 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.88214706 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.84869081 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.80904094 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.80855005 |
| 19 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.68755184 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.63105952 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 1.62790832 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.60848799 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55472609 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.53428518 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.47914512 |
| 26 | Bladder cancer_Homo sapiens_hsa05219 | 1.44948944 |
| 27 | Tight junction_Homo sapiens_hsa04530 | 1.44213408 |
| 28 | Endometrial cancer_Homo sapiens_hsa05213 | 1.43723198 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42246269 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.37281231 |
| 31 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.35621594 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35080239 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.34677453 |
| 34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32086364 |
| 35 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.29665241 |
| 36 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.28007876 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.22298147 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21191874 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19246469 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.16800832 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15946044 |
| 42 | Adherens junction_Homo sapiens_hsa04520 | 1.14935380 |
| 43 | Olfactory transduction_Homo sapiens_hsa04740 | 1.12179285 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10464324 |
| 45 | Taste transduction_Homo sapiens_hsa04742 | 1.08221526 |
| 46 | Morphine addiction_Homo sapiens_hsa05032 | 1.04356071 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02936882 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02648602 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 1.02105673 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99648878 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.98708136 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97702930 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.97452837 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.96323693 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95942003 |
| 56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.94899310 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.94875916 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.93677386 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93549676 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91462432 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91449914 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88789491 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88451643 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 0.88290052 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87955440 |
| 66 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.86207187 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86065740 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85360322 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85355173 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84608282 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84477559 |
| 72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.83882096 |
| 73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.83365965 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.82051744 |
| 75 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81092152 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80829444 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79889561 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 0.79509662 |
| 79 | Glioma_Homo sapiens_hsa05214 | 0.79463994 |
| 80 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79263097 |
| 81 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75517640 |
| 82 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.75473407 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.74804647 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74262226 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73690557 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73012815 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72920614 |
| 88 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.72800804 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.72509978 |
| 90 | Homologous recombination_Homo sapiens_hsa03440 | 0.72455762 |
| 91 | GABAergic synapse_Homo sapiens_hsa04727 | 0.71669078 |
| 92 | Melanoma_Homo sapiens_hsa05218 | 0.70891081 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70537618 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.70348412 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.69615106 |
| 96 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.69488166 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69313322 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69297123 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68334841 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67660804 |
| 101 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.66744058 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65061191 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64696019 |
| 104 | Ribosome_Homo sapiens_hsa03010 | 0.64485135 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63130931 |
| 106 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.63089961 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62979439 |
| 108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62966286 |
| 109 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62959790 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62666315 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.61149885 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59374738 |
| 113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59286566 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58798786 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58706169 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58661586 |
| 117 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57745781 |
| 118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57116889 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57107965 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56273528 |
| 121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54328476 |
| 122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53363933 |
| 123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.52489639 |
| 124 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51743048 |
| 125 | Alzheimers disease_Homo sapiens_hsa05010 | 0.50243791 |
| 126 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49152335 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48964989 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47977028 |
| 129 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46486192 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45455260 |
| 131 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45348168 |
| 132 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44641337 |
| 133 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.44247469 |
| 134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44132670 |
| 135 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43996354 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43878077 |
| 137 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.42889402 |
| 138 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.42841158 |
| 139 | RNA polymerase_Homo sapiens_hsa03020 | 0.42657001 |
| 140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42003339 |
| 141 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41970722 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41656078 |
| 143 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41652163 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.41278285 |
| 145 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41090520 |
| 146 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40920153 |
| 147 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.40756611 |
| 148 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.40651551 |
| 149 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40460796 |
| 150 | Renin secretion_Homo sapiens_hsa04924 | 0.39685963 |
| 151 | RNA degradation_Homo sapiens_hsa03018 | 0.38547505 |
| 152 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38071024 |
| 153 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37731296 |
| 154 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37672651 |
| 155 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36206003 |
| 156 | Gap junction_Homo sapiens_hsa04540 | 0.35996787 |
| 157 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.33972079 |
| 158 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32288192 |
| 159 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.32209573 |
| 160 | Huntingtons disease_Homo sapiens_hsa05016 | 0.32151092 |
| 161 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.31686513 |
| 162 | Phagosome_Homo sapiens_hsa04145 | 0.31586277 |
| 163 | Insulin secretion_Homo sapiens_hsa04911 | 0.29367293 |
| 164 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.28936381 |
| 165 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28871589 |
| 166 | Mineral absorption_Homo sapiens_hsa04978 | 0.28774598 |
| 167 | Cocaine addiction_Homo sapiens_hsa05030 | 0.27073386 |
| 168 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26065154 |
| 169 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25616153 |
| 170 | Melanogenesis_Homo sapiens_hsa04916 | 0.24927353 |
| 171 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24565077 |
| 172 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.24323269 |

